ROIV,MP Stock Price and Quote

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.21
Percentage change -1.82	%

Peers: VRTX REGN BIIB BMRN ALNY CRSP INCY NBIX IONS EDIT

| Held by: IJH VTI VB XBI VXF VBK MDY IBB IJK SPMD

Index	-	P/E	-	EPS (ttm)	-0.25	Insider Own	40.97%	Shs Outstand	695.94M	Perf Week	3.37%
Market Cap	7.72B	Forward P/E	-	EPS next Y	-1.29	Insider Trans	-2.01%	Shs Float	401.31M	Perf Month	-0.09%
Enterprise Value	3.43B	PEG	-	EPS next Q	-0.25	Inst Own	65.73%	Short Float	10.24%	Perf Quarter	14.86%
Income	-171.98M	P/S	101.36	EPS this Y	-393.55%	Inst Trans	-9.50%	Short Ratio	6.45	Perf Half Y	-1.39%
Sales	76.19M	P/B	1.69	EPS next Y	-8.50%	ROA	-7.20%	Short Interest	41.10M	Perf YTD	-3.97%
Book/sh	6.74	P/C	1.58	EPS next 5Y	-	ROE	-8.56%	52W High	13.06 -12.98%	Perf Year	4.89%
Cash/sh	7.19	P/FCF	-	EPS past 3/5Y	42.73% -99.51%	ROIC	-3.60%	52W Low	8.73 30.13%	Perf 3Y	135.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-19.30% -	Gross Margin	96.95%	Volatility	2.84% 2.87%	Perf 5Y	-
Dividend TTM	-	EV/Sales	45.06	EPS Y/Y TTM	-104.46%	Oper. Margin	-1485.18%	ATR (14)	0.33	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	33.47	Sales Y/Y TTM	-38.94%	Profit Margin	-225.71%	RSI (14)	53.79	Recom	1.18
Dividend Gr. 3/5Y	- -	Current Ratio	33.47	EPS Q/Q	-55.10%	SMA20	0.88%	Beta	1.15	Target Price	16.38
Payout	-	Debt/Eq	0.02	Sales Q/Q	-73.83%	SMA50	1.90%	Rel Volume	0.80	Prev Close	11.57
Employees	750	LT Debt/Eq	0.02	Earnings	May 29 BMO	SMA200	1.61%	Avg Volume	6.37M	Price	11.36
IPO	Dec 08, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.06% -86.00%	Trades		Volume	5,069,511	Change	-1.82%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-25	Resumed	Goldman	Buy	$19
Feb-15-24	Initiated	Wolfe Research	Outperform	$17
Jan-05-24	Initiated	Piper Sandler	Overweight	$20
Dec-12-23	Initiated	Deutsche Bank	Buy	$14
Oct-17-23	Initiated	Guggenheim	Buy	$17
Jun-08-23	Initiated	BofA Securities	Neutral	$10.50
Oct-27-22	Initiated	JP Morgan	Overweight	$7
May-23-22	Initiated	SVB Leerink	Outperform	$6
Apr-29-22	Initiated	Cantor Fitzgerald	Overweight	$15
Dec-15-21	Initiated	Goldman	Buy	$15
Nov-08-21	Initiated	H.C. Wainwright	Buy	$14
Oct-28-21	Initiated	Citigroup	Buy	$11
Oct-26-21	Initiated	Truist	Buy	$15
Oct-26-21	Initiated	Jefferies	Buy	$10
Oct-26-21	Initiated	Cowen	Outperform

Show Previous Ratings

Jul-11-25 06:20AM	Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar? (Zacks)
Jun-24-25 12:45PM	Roivant Sciences Subsidiary Pulmovant Publishes Positive Phase 1 Data for Inhaled PH Treatment Mosliciguat (Insider Monkey)
Jun-16-25 07:00AM	Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics (GlobeNewswire)
Jun-09-25 04:05PM	Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis (GlobeNewswire)
May-29-25 08:15AM	Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +6.40%
07:00AM	Loading…
07:00AM	Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update (GlobeNewswire)
May-28-25 02:17PM	H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock (Insider Monkey)
09:15AM	What To Expect From Roivant Sciences Ltd (ROIV) Q4 2025 Earnings (GuruFocus.com)
May-15-25 05:15PM	Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:10PM	Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025 (GlobeNewswire)
May-14-25 05:40PM	Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-13-25 05:10PM	Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-08-25 07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-06-25 06:20AM	Should Invesco S&P MidCap 400 Pure Growth ETF (RFG) Be on Your Investing Radar? (Zacks)
May-02-25 10:37AM	Roivant Sciences Ltd. (ROIV): Among David Einhorn's Stock Picks with Huge Upside Potential (Insider Monkey)
11:35AM	Loading…
Apr-29-25 11:35AM	Roivant Sciences Ltd. (ROIV): Among Billionaire Andreas Halvorsen's Stock Picks With Huge Upside Potential (Insider Monkey)
Apr-23-25 12:13PM	Roivant Sciences: Primed For Growth With A De-Risked Pipeline (Seeking Alpha)
Apr-21-25 04:08PM	Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug (Investor's Business Daily)
10:18AM	Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift (Investor's Business Daily)
07:00AM	Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjogren's Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402 (GlobeNewswire)
07:00AM	Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sj gren's Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402 (GlobeNewswire)
Apr-14-25 06:20AM	Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now? (Zacks)
Apr-11-25 03:07PM	Is Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? (Insider Monkey)
10:04AM	Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock? (Zacks)
Apr-10-25 05:08PM	Roivant Sciences Ltd. (ROIV): Among the Best Low Priced Growth Stocks to Invest In (Insider Monkey)
Mar-31-25 04:03PM	Impax Small Cap Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 04:00PM	Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? (Insider Monkey)
Mar-25-25 02:12PM	Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn? (InsiderMonkey)
Mar-19-25 04:04PM	Roivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rose. (Investor's Business Daily)
09:26AM	Roivant, Immunovant Succeed In Phase 3. But There's A Twist And Shares Tumbled. (Investor's Business Daily)
07:45AM	Loading…
07:45AM	Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies (GlobeNewswire)
Mar-18-25 04:32PM	Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs (GlobeNewswire)
Mar-03-25 09:15AM	Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna (GlobeNewswire) -5.31%
Feb-25-25 08:00AM	Early Warning Report Issued Pursuant to National Instrument 62 103: Roivant announces Resignation and Replacement of Arbutus Board (GlobeNewswire)
Feb-12-25 10:00AM	Roivant Sciences price target lowered to $12 from $13 at BofA (TipRanks)
Feb-10-25 07:00AM	Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update (GlobeNewswire)
Feb-07-25 07:06AM	What To Expect From Roivant Sciences Ltd (ROIV) Q3 2025 Earnings (GuruFocus.com)
Feb-03-25 07:00AM	Zest Health Announces $13M in Funding to Curb Unnecessary Pharmaceutical Spend through High-Touch Care (GlobeNewswire)
Jan-29-25 04:05PM	Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025 (GlobeNewswire)
Jan-15-25 08:49PM	Vivek Ramaswamy Open to Replacing JD Vance in Senateif Offered (The Wall Street Journal)
Jan-12-25 09:40AM	Is Roivant Sciences (ROIV) the Best Medical Stock to Buy Under $20? (Insider Monkey)
Jan-02-25 03:28AM	Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing (Insider Monkey)
Dec-03-24 07:00AM	Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis (GlobeNewswire)
07:00AM	Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis (GlobeNewswire)
Nov-15-24 05:01PM	Vivek Ramaswamy's Net Worth Is 9 Figures See How the DOGE Co-Lead Made His Millions (Investopedia)
Nov-12-24 07:00AM	Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update (GlobeNewswire)
Nov-11-24 07:04AM	Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-29-24 04:35PM	Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024 (GlobeNewswire)
Oct-28-24 09:25AM	Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA (tapinarof) Cream, 1% (GlobeNewswire)
Sep-18-24 07:30AM	Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA (tapinarof) Cream, 1% (GlobeNewswire)
Sep-10-24 06:30AM	Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator (GlobeNewswire)
06:30AM	Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress (GlobeNewswire)
Sep-09-24 07:00AM	Roivant Provides Update on Graves' Disease Development Program (GlobeNewswire)
Sep-04-24 06:55PM	The Federal Reserve should refresh its mandate: Former presidential candidate Vivek Ramaswamy (Yahoo Finance)
Aug-08-24 07:00AM	Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update (GlobeNewswire) +6.69%
Jul-25-24 04:05PM	Roivant to Report Financial Results for the First Quarter Ended June 30, 2024, and Provide Business Update on Thursday, August 8, 2024 (GlobeNewswire)
May-31-24 08:04AM	Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2023 Earnings Call Transcript (Insider Monkey)
May-30-24 11:53AM	ROIV Stock Earnings: Roivant Sciences Beats EPS, Misses Revenue for Q4 2024 (InvestorPlace)
08:20AM	Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update (GlobeNewswire)
May-27-24 06:28PM	Institutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV) (Insider Monkey)
06:13PM	7 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
May-16-24 04:05PM	Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024 (GlobeNewswire)
May-08-24 02:43AM	Greenlight Capital Initiated a Position in Roivant Sciences (ROIV) in Q1 (Insider Monkey)
May-07-24 02:04PM	Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare (InvestorPlace)
May-01-24 10:47AM	3 Healthcare Stocks With the Potential to Triple Your Investment by 2026 (InvestorPlace)
Apr-25-24 08:00AM	Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis (Business Wire)
Apr-12-24 11:09AM	10 Most Undervalued Stocks to Buy for Under $20 (Insider Monkey)
Apr-02-24 07:00AM	Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million (GlobeNewswire)
Mar-27-24 01:55PM	Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck (The Wall Street Journal) +7.54%
Mar-26-24 06:22PM	Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600 (PR Newswire)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 07:04AM	10 Stocks George Soros and Insiders Are Crazy About (Insider Monkey)
Feb-15-24 02:45AM	Do You Think the Management of Roivant Sciences (ROIV) Can Create Value? (Insider Monkey)
Feb-13-24 07:00AM	Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update (GlobeNewswire)
Feb-10-24 02:55AM	Roivant Sciences Ltd President & COO Eric Venker Sells 96,950 Shares (GuruFocus.com)
Jan-30-24 04:05PM	Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024 (GlobeNewswire)
Dec-27-23 08:05PM	5 High Growth International Stocks to Buy (Insider Monkey)
Dec-20-23 04:30PM	Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves' Disease (GlobeNewswire) -7.78% +5.82%
Dec-14-23 09:00AM	Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease (GlobeNewswire)
Nov-28-23 07:00AM	Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential (GlobeNewswire)
02:38AM	5 Stocks Under $20 To Buy Now (Insider Monkey)
Nov-27-23 08:00AM	Roivant and Priovant Announce Results from Phase 2 Study of Oral Brepocitinib in Systemic Lupus Erythematosus (GlobeNewswire)
Nov-14-23 01:00PM	Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2023 Earnings Call Transcript (Insider Monkey)
Nov-13-23 07:00AM	Roivant Reports Financial Results for the Second Quarter Ended September 30, 2023, and Provides Business Update (GlobeNewswire)
Nov-10-23 08:00AM	Roivant Announces Appointment of Mayukh Sukhatme to Its Board of Directors (GlobeNewswire)
Oct-30-23 05:30PM	Roivant to Report Financial Results for the Second Quarter Ended September 30, 2023, and Provide Business Update on Monday, November 13, 2023 (GlobeNewswire)
Oct-24-23 08:00AM	This $5 Billion Biotech Home Run Took Less Than a Year (The Wall Street Journal)
Oct-23-23 03:02PM	Roivant Sciences Sells Joint Venture With Pfizer to Roche for $7.1 Billion (Investopedia) -11.02%
10:31AM	Why Is Roivant Sciences (ROIV) Stock Up Today? (InvestorPlace)
09:52AM	Roche acquires Telavant, rights to bowel disease drug (Yahoo Finance Video)
06:55AM	Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion (The Wall Street Journal)
03:49AM	Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Bln Deal (The Wall Street Journal)
01:00AM	Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease From Roivant (GlobeNewswire)
Oct-13-23 08:00AM	Covant Therapeutics Appoints Vincent Hennemand as Chief Executive Officer (GlobeNewswire)
Oct-05-23 05:01AM	Insider Sell: Eric Venker Sells 1,200,000 Shares of Roivant Sciences Ltd (ROIV) (GuruFocus.com) +5.04%
Oct-03-23 07:00AM	Vivek Ramaswamys Former Company Is Doing Just Fine Without Him (The Wall Street Journal)
Sep-30-23 05:00AM	Insider Sell: President & COO Eric Venker Sells 500,000 Shares of Roivant Sciences Ltd (ROIV) (GuruFocus.com)
Sep-26-23 06:00AM	Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results (GlobeNewswire) +21.55%
Sep-11-23 08:00AM	Roivant Announces Completion of Redemption of its Outstanding Warrants (GlobeNewswire) -8.65%

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Venker Eric	President & COO	Jun 20 '25	Option Exercise	3.85	100,000	385,000	1,562,223	Jun 24 09:01 PM
Venker Eric	President & COO	Jun 20 '25	Sale	11.45	100,000	1,145,000	1,462,223	Jun 24 09:01 PM
Ramaswamy Vivek	10% Owner	Jun 20 '25	Sale	11.46	577,007	6,612,500	37,284,108	Jun 23 11:35 AM
Ramaswamy Vivek	10% Owner	Jun 18 '25	Sale	11.45	565,266	6,472,296	37,861,115	Jun 23 11:35 AM
Ramaswamy Vivek	10% Owner	Jun 20 '25	Proposed Sale	11.46	577,007	6,611,850		Jun 20 04:35 PM
Venker Eric	Officer	Jun 20 '25	Proposed Sale	11.45	100,000	1,145,268		Jun 20 04:13 PM
Ramaswamy Vivek	10% Owner	Jun 18 '25	Proposed Sale	11.45	565,266	6,472,996		Jun 18 04:38 PM
Ramaswamy Vivek	10% Owner	Jun 04 '25	Sale	11.34	547,430	6,207,856	38,627,181	Jun 06 05:49 PM
Ramaswamy Vivek	10% Owner	Jun 06 '25	Sale	11.19	200,800	2,246,952	38,426,381	Jun 06 05:49 PM
Ramaswamy Vivek	10% Owner	Jun 06 '25	Proposed Sale	11.19	200,800	2,246,311		Jun 06 04:33 PM
Venker Eric	President & COO	Jun 03 '25	Option Exercise	3.85	785,026	3,022,350	2,028,501	Jun 04 09:00 PM
Venker Eric	President & COO	Jun 02 '25	Option Exercise	3.85	600,000	2,310,000	1,677,197	Jun 04 09:00 PM
Venker Eric	President & COO	Jun 03 '25	Sale	11.22	566,278	6,353,639	1,462,223	Jun 04 09:00 PM
Venker Eric	President & COO	Jun 02 '25	Sale	11.07	433,722	4,801,303	1,243,475	Jun 04 09:00 PM
Ramaswamy Vivek	10% Owner	Jun 04 '25	Proposed Sale	11.34	547,430	6,208,008		Jun 04 04:42 PM
ERIC VENKER	Officer	Jun 03 '25	Proposed Sale	11.22	566,278	6,355,961		Jun 03 05:14 PM
ERIC VENKER	Officer	Jun 02 '25	Proposed Sale	11.07	433,722	4,803,341		Jun 02 04:16 PM
Venker Eric	President & COO	May 20 '25	Option Exercise	3.85	100,000	385,000	1,177,197	May 22 09:00 PM
Venker Eric	President & COO	May 20 '25	Sale	10.95	100,000	1,095,000	1,077,197	May 22 09:00 PM
Venker Eric	Officer	May 20 '25	Proposed Sale	10.95	100,000	1,094,986		May 20 04:30 PM
Ramaswamy Vivek	10% Owner	May 07 '25	Sale	11.18	625,000	6,987,500	39,174,611	May 08 08:51 PM
Ramaswamy Vivek	10% Owner	May 06 '25	Sale	11.47	273,959	3,142,310	39,799,611	May 08 08:51 PM
Ramaswamy Vivek	10% Owner	May 07 '25	Proposed Sale	11.18	625,000	6,987,388		May 07 04:37 PM
Ramaswamy Vivek	10% Owner	May 06 '25	Proposed Sale	11.47	273,959	3,143,287		May 06 04:21 PM
Venker Eric	President & COO	Apr 21 '25	Option Exercise	3.85	100,000	385,000	1,216,345	Apr 22 09:00 PM
Venker Eric	President & COO	Apr 21 '25	Sale	10.22	100,000	1,022,000	1,116,345	Apr 22 09:00 PM
Venker Eric	Officer	Apr 21 '25	Proposed Sale	10.22	100,000	1,022,374		Apr 21 03:22 PM
Venker Eric	President & COO	Mar 24 '25	Option Exercise	3.85	602,311	2,318,897	1,561,768	Mar 24 09:21 PM
Venker Eric	President & COO	Mar 20 '25	Option Exercise	3.85	400,000	1,540,000	1,274,979	Mar 24 09:21 PM
Venker Eric	President & COO	Mar 24 '25	Sale	10.82	434,478	4,701,052	1,127,290	Mar 24 09:21 PM
Venker Eric	President & COO	Mar 20 '25	Sale	11.06	315,522	3,489,673	959,457	Mar 24 09:21 PM
Venker Eric	Officer	Mar 20 '25	Proposed Sale	10.95	650,000	7,117,500		Mar 20 05:27 PM
Venker Eric	Officer	Mar 20 '25	Proposed Sale	11.11	100,000	1,110,537		Mar 20 03:54 PM
Venker Eric	President & COO	Feb 20 '25	Option Exercise	3.85	100,000	385,000	996,869	Feb 24 09:00 PM
Venker Eric	President & COO	Feb 20 '25	Sale	10.65	100,000	1,065,000	896,869	Feb 24 09:00 PM
Venker Eric	Officer	Feb 20 '25	Proposed Sale	10.65	100,000	1,065,022		Feb 20 03:35 PM
Kumar Rakhi	Chief Accounting Officer	Feb 13 '25	Option Exercise	3.85	187,500	721,875	390,764	Feb 18 09:00 PM
Kumar Rakhi	Chief Accounting Officer	Feb 13 '25	Sale	10.43	227,500	2,372,825	163,264	Feb 18 09:00 PM
Venker Eric	President & COO	Feb 12 '25	Option Exercise	3.85	300,000	1,155,000	1,032,294	Feb 14 09:00 PM
Venker Eric	President & COO	Feb 13 '25	Option Exercise	3.85	300,000	1,155,000	1,114,910	Feb 14 09:00 PM
Venker Eric	President & COO	Feb 12 '25	Sale	10.53	217,384	2,289,054	732,294	Feb 14 09:00 PM
Venker Eric	President & COO	Feb 13 '25	Sale	10.42	218,041	2,271,987	896,869	Feb 14 09:00 PM
Kumar Rakhi	Officer	Feb 13 '25	Proposed Sale	10.43	227,500	2,372,966		Feb 13 05:14 PM
Venker Eric	Officer	Feb 12 '25	Proposed Sale	10.50	600,000	6,300,000		Feb 12 05:29 PM
Venker Eric	President & COO	Jan 21 '25	Option Exercise	3.85	100,000	385,000	832,294	Jan 22 09:04 PM
Venker Eric	President & COO	Jan 21 '25	Sale	11.28	100,000	1,128,000	732,294	Jan 22 09:04 PM
Venker Eric	Officer	Jan 21 '25	Proposed Sale	11.28	100,000	1,128,457		Jan 21 04:30 PM
Roivant Sciences Ltd.	Director	Jan 13 '25	Buy	20.00	16,845,010	336,900,200	96,650,341	Jan 15 04:36 PM
Venker Eric	President & COO	Dec 27 '24	Option Exercise	3.85	250,000	962,500	845,580	Dec 31 09:00 PM
Venker Eric	President & COO	Dec 30 '24	Option Exercise	3.85	250,000	962,500	918,680	Dec 31 09:00 PM
Venker Eric	President & COO	Dec 27 '24	Sale	11.82	176,900	2,090,958	668,680	Dec 31 09:00 PM
Venker Eric	President & COO	Dec 30 '24	Sale	11.54	177,704	2,050,704	740,976	Dec 31 09:00 PM
Venker Eric	Officer	Dec 27 '24	Proposed Sale	11.75	360,000	4,230,000		Dec 27 04:54 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 26 '24	Option Exercise	3.85	689,495	2,654,556	19,526,042	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 24 '24	Option Exercise	3.85	185,946	715,892	19,022,493	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 23 '24	Option Exercise	3.85	10,796	41,565	18,847,343	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 26 '24	Sale	12.01	689,495	8,280,835	18,836,547	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 24 '24	Sale	12.00	185,946	2,231,352	18,836,547	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 23 '24	Sale	12.00	10,796	129,552	18,836,547	Dec 26 09:00 PM
Venker Eric	President & COO	Dec 20 '24	Option Exercise	3.85	100,000	385,000	695,580	Dec 26 09:00 PM
Venker Eric	President & COO	Dec 20 '24	Sale	11.49	100,000	1,149,000	595,580	Dec 26 09:00 PM
Sukhatme Mayukh	Officer	Dec 26 '24	Proposed Sale	12.01	689,495	8,277,401		Dec 26 04:14 PM
Sukhatme Mayukh	Officer	Dec 24 '24	Proposed Sale	12.00	185,946	2,231,700		Dec 26 08:02 AM
Sukhatme Mayukh	Officer	Dec 23 '24	Proposed Sale	12.00	10,796	129,555		Dec 23 04:21 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 18 '24	Option Exercise	3.85	412,584	1,588,448	19,249,131	Dec 20 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 18 '24	Sale	12.05	412,584	4,971,637	18,836,547	Dec 20 09:00 PM
Venker Eric	Officer	Nov 20 '24	Proposed Sale	11.49	100,000	1,148,554		Dec 20 04:29 PM
Sukhatme Mayukh	Officer	Dec 18 '24	Proposed Sale	12.05	412,584	4,969,631		Dec 18 04:33 PM
Venker Eric	President & COO	Nov 20 '24	Option Exercise	3.85	100,000	385,000	706,525	Nov 22 09:00 PM
Venker Eric	President & COO	Nov 20 '24	Sale	11.32	100,000	1,132,000	606,525	Nov 22 09:00 PM
Venker Eric	Officer	Nov 20 '24	Proposed Sale	11.32	100,000	1,132,008		Nov 20 04:45 PM
Venker Eric	President & COO	Oct 21 '24	Option Exercise	3.85	100,000	385,000	717,470	Oct 22 09:00 PM
Venker Eric	President & COO	Oct 21 '24	Sale	11.65	100,000	1,165,000	617,470	Oct 22 09:00 PM
Venker Eric	Officer	Oct 21 '24	Proposed Sale	11.65	100,000	1,165,393		Oct 21 04:45 PM
QVT Financial LP	Director by Deputization	Sep 26 '24	Sale	11.82	876,000	10,354,320	22,179,358	Sep 26 09:22 PM
QVT Financial LP	Director by Deputization	Sep 25 '24	Sale	11.77	50,000	588,500	23,055,358	Sep 26 09:22 PM
MANCHESTER KEITH S	Director	Sep 24 '24	Sale	11.62	368,052	4,278,604	1,412,126	Sep 26 08:35 PM
MANCHESTER KEITH S	Director	Sep 25 '24	Sale	11.77	134,948	1,587,704	1,277,178	Sep 26 08:35 PM
Gold Daniel Allen	Director	Sep 24 '24	Sale	11.62	1,565,670	18,200,914	5,723,423	Sep 26 08:34 PM
Gold Daniel Allen	Director	Sep 25 '24	Sale	11.77	991,593	11,666,389	4,731,830	Sep 26 08:34 PM
Gold Daniel Allen	Director	Sep 26 '24	Sale	11.82	876,000	10,354,320	22,179,358	Sep 26 08:34 PM
Gold Daniel Allen	Director	Sep 24 '24	Sale	11.62	577,186	6,709,787	2,079,059	Sep 26 08:34 PM
Gold Daniel Allen	Director	Sep 25 '24	Sale	11.77	415,551	4,889,317	1,713,508	Sep 26 08:34 PM
BNEI ZAHAV LLC	Director	Sep 25 '24	Proposed Sale	11.76	23,917	281,264		Sep 25 04:30 PM
RIOJA DOLCE LLC	Director	Sep 25 '24	Proposed Sale	11.76	170,817	2,008,808		Sep 25 04:25 PM
KEITH S MANCHESTER REVOCABLE T	Director	Sep 25 '24	Proposed Sale	11.76	134,948	1,586,988		Sep 25 04:23 PM
RIOJA LIETO LLC	Director	Sep 25 '24	Proposed Sale	11.76	170,817	2,008,808		Sep 25 04:20 PM
DANIEL GOLD & LAURA GOLD	Director	Sep 25 '24	Proposed Sale	11.76	991,593	11,661,134		Sep 25 04:19 PM
Gline Matthew	CEO	Sep 23 '24	Option Exercise	3.85	1,550,000	5,967,500	19,853,800	Sep 24 09:01 PM
Gline Matthew	CEO	Sep 23 '24	Sale	11.79	1,983,257	23,382,600	17,870,543	Sep 24 09:01 PM
Kumar Rakhi	Chief Accounting Officer	Sep 23 '24	Option Exercise	3.85	250,000	962,500	459,322	Sep 24 09:01 PM
Kumar Rakhi	Chief Accounting Officer	Sep 23 '24	Sale	11.89	250,000	2,972,500	209,322	Sep 24 09:01 PM
DANIEL GOLD &LAURA GOLD JT TEN	Director	Sep 24 '24	Proposed Sale	11.62	1,565,670	18,200,914		Sep 24 07:53 PM
RIOJA LIETO LLC	Director	Sep 24 '24	Proposed Sale	11.63	269,712	3,135,402		Sep 24 07:52 PM
RIOJA DOLCE LLC	Director	Sep 24 '24	Proposed Sale	11.63	269,712	3,135,402		Sep 24 07:51 PM
BNEI ZAHAV LLC	Director	Sep 24 '24	Proposed Sale	11.62	37,762	438,983		Sep 24 07:48 PM
KEITH S MANCHESTER REVOCABLE T	Director	Sep 24 '24	Proposed Sale	11.63	368,052	4,281,550		Sep 24 07:43 PM
Gline Matthew	Officer	Sep 23 '24	Proposed Sale	11.79	1,983,257	23,383,088		Sep 23 04:53 PM
Kumar Rakhi	Officer	Sep 23 '24	Proposed Sale	11.89	250,000	2,972,360		Sep 23 04:47 PM

Dollar change -0.12
Percentage change -0.27	%

MP MP Materials Corporation daily Stock Chart

Peers: REE

| Held by: IJR XME VTI VB SPSM VXF VBK REMX IJS SCHA

Index	-	P/E	-	EPS (ttm)	-0.64	Insider Own	26.80%	Shs Outstand	163.45M	Perf Week	41.68%
Market Cap	7.37B	Forward P/E	-	EPS next Y	-0.01	Insider Trans	-5.36%	Shs Float	119.66M	Perf Month	65.66%
Enterprise Value	7.53B	PEG	-	EPS next Q	-0.19	Inst Own	69.72%	Short Float	25.81%	Perf Quarter	89.46%
Income	-104.56M	P/S	34.14	EPS this Y	-31.39%	Inst Trans	5.27%	Short Ratio	2.78	Perf Half Y	119.19%
Sales	215.98M	P/B	7.12	EPS next Y	97.43%	ROA	-4.43%	Short Interest	30.88M	Perf YTD	189.17%
Book/sh	6.34	P/C	9.70	EPS next 5Y	-	ROE	-9.62%	52W High	48.12 -6.25%	Perf Year	216.78%
Cash/sh	4.65	P/FCF	-	EPS past 3/5Y	- -41.29%	ROIC	-5.55%	52W Low	10.02 350.20%	Perf 3Y	49.77%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-15.00% 22.66%	Gross Margin	-33.21%	Volatility	9.02% 7.90%	Perf 5Y	355.66%
Dividend TTM	-	EV/Sales	34.87	EPS Y/Y TTM	-3189.81%	Oper. Margin	-71.90%	ATR (14)	3.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.58	Sales Y/Y TTM	4.63%	Profit Margin	-48.41%	RSI (14)	74.26	Recom	1.64
Dividend Gr. 3/5Y	- -	Current Ratio	4.12	EPS Q/Q	-71.59%	SMA20	30.34%	Beta	2.24	Target Price	35.70
Payout	-	Debt/Eq	0.89	Sales Q/Q	24.91%	SMA50	64.48%	Rel Volume	3.33	Prev Close	45.23
Employees	804	LT Debt/Eq	0.82	Earnings	May 08 AMC	SMA200	98.67%	Avg Volume	11.12M	Price	45.11
IPO	Jun 22, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.98% -3.73%	Trades		Volume	37,075,581	Change	-0.27%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-07-25	Downgrade	Jefferies	Buy → Hold	$33
Jun-05-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$34
Sep-27-24	Reiterated	Robert W. Baird	Outperform	$20 → $25
Jul-15-24	Initiated	BMO Capital Markets	Market Perform	$16.50
Apr-23-24	Downgrade	JP Morgan	Overweight → Neutral	$20 → $16
Mar-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$26 → $15.50
Sep-06-23	Upgrade	Northland Capital	Market Perform → Outperform
Aug-31-23	Initiated	JP Morgan	Overweight	$27
Apr-18-23	Downgrade	Northland Capital	Outperform → Market Perform	$32
Jul-13-22	Initiated	Canaccord Genuity	Buy	$44
Jun-06-22	Resumed	Northland Capital	Outperform	$60
Jun-01-22	Initiated	BMO Capital Markets	Outperform	$50
Feb-09-22	Upgrade	The Benchmark Company	Hold → Buy	$47
Nov-30-21	Resumed	BofA Securities	Buy	$52
Nov-11-21	Initiated	The Benchmark Company	Hold
Nov-11-21	Initiated	Jefferies	Buy	$55
Jul-23-21	Initiated	DA Davidson	Buy	$45
Jun-30-21	Initiated	Robert W. Baird	Outperform	$45
Jun-16-21	Initiated	JP Morgan	Overweight	$41
Apr-01-21	Initiated	BofA Securities	Neutral	$38

Show Previous Ratings

Today 07:30AM	'Story' stocks are smoking hot in 2025. This is how it could end badly for investors. (MarketWatch)
Jul-11-25 04:39PM	The Score: WK Kellogg, Nvidia, Delta Air Lines and More Stocks That Defined the Week (The Wall Street Journal)
04:28PM	Boom. Rare-Earth Stock Gets Huge Target-Price Boost. Shares Jump Again. (Barrons.com)
04:04PM	Why MP Materials Soared 50% After This Pentagon Rare Earths Deal (Investor's Business Daily)
11:37AM	MP Materials Hits 52-Week High: Should You Buy, Hold or Sell? (Zacks)
10:59AM	Loading…
10:59AM	Why MP Materials Stock Is Racing Higher (Again) Today (Motley Fool)
09:22AM	'Boom.' Rare-Earth Stock Gets Huge Target-Price Boost. (Barrons.com)
09:00AM	Why MP Materials Skyrocketed This Week (Motley Fool)
07:58AM	Stellantis, MP Materials, Levi's earnings: Trending Tickers (Yahoo Finance Video)
07:06AM	Why MP Materials Is Up More Than 50% After This Pentagon Rare Earths Deal (Investor's Business Daily)
06:30AM	Pentagon to Take $400 Million Stake in Rare Earth Miner Outside Vegas (The Daily Upside)
05:05AM	MP Materials and DoD to expand US rare earth magnet supply chain (Mining Technology)
04:48AM	MP Materials (MP) Moves 50.6% Higher: Will This Strength Last? (Zacks)
02:05AM	Australian rare earth stocks soar on MP Materials' multi-billion US deal (Reuters)
Jul-10-25 11:52PM	Pentagon Buys Rare Earths Stake to Tackle Chinas Dominance (Bloomberg) +50.62%
06:18PM	Loading…
06:18PM	The Pentagon is taking a big stake in a rare earth mining company, sending the stock up 60% (Business Insider)
05:33PM	Pentagon strikes investment deal with US critical minerals producer (Financial Times)
05:12PM	Stocks to Watch Recap: Delta, Kellogg, Nvidia, TSMC (The Wall Street Journal)
04:53PM	These Stocks Moved the Most Today: Nvidia, Delta, WK Kellogg, MP Materials, Vertiv, Helen of Troy, and More (Barrons.com)
04:47PM	Stock Market Today: Small Caps Rise, Edging Dow; Travel Firms Jump On Oil Drop But Byrna, Axon Trip Sell Rules (Live Coverage) (Investor's Business Daily)
04:21PM	MP Materials Stock Soars 51% on a Defense Pact for Rare Earths (Barrons.com)
04:18PM	Pentagon Invests in Rare Earth Magnet Producer (Bloomberg)
03:47PM	MP Materials stock surges as Pentagon becomes top shareholder (Yahoo Finance Video)
03:28PM	Stock Market Today: Dow Up Nearly 300 Points; Rare Earths Play Soars, But These Firms Trip Sell Rules (Live Coverage) (Investor's Business Daily)
02:26PM	These Stocks Are Moving the Most Today: Nvidia, Delta, WK Kellogg, MP Materials, Vertiv, Helen of Troy, and More (Barrons.com)
01:05PM	The Pentagon Just Made a Huge Bet on MP Materials. How Should You Play MP Stock Here? (Barchart)
12:57PM	MP Materials CEO on deal with the Defense Department (CNBC TV)
12:51PM	Stocks to Watch Thursday: Delta, Kellogg, Nvidia, TSMC (The Wall Street Journal)
12:13PM	Why Energy Fuels Stock Popped Today (Motley Fool)
11:46AM	Why MP Materials Stock Soared Today (Motley Fool)
11:40AM	Loading…
11:40AM	Can MP and DoD Rebuild America's Rare Earth Magnet Supply Chain? (Zacks)
10:57AM	Cramer's Mad Dash: MP Materials Corp. (CNBC TV)
10:43AM	AMD & Roku upgraded, MP Materials skyrockets: Trending Tickers (Yahoo Finance Video)
10:12AM	Deals Roundup: Ferrero Buys WK Kellogg, DOD Invests in MP (Bloomberg)
09:32AM	MP Materials Stock Surges After Rare-Earth Miner Strikes Pentagon Deal (The Wall Street Journal)
09:29AM	Pentagon to Take Stake in Rare-Earth Company, Challenging Chinas Control (The Wall Street Journal)
08:59AM	MP Materials Stock Surges 50% on Rare Earths Contract With Defense Department (Investopedia)
08:51AM	MP Materials won a big rare-earth contract with Uncle Sam, and the stock rockets (MarketWatch)
08:50AM	MP Materials (MP) Drops on Stock Rating Downgrade (Insider Monkey)
08:04AM	Why MP Materials Is Up More Than 40% After This Pentagon Rare Earths Deal (Investor's Business Daily)
07:52AM	Kellogg shares soar on buyout talk, and other early market movers (MarketWatch)
07:35AM	MP Materials Enters Multibillion-Dollar Partnership With Defense Dept (The Wall Street Journal)
07:18AM	MP Materials Stock Soars 43% on Defense Department Agreements for Rare Earth Magnets (Barrons.com)
06:40AM	MP Materials partners with Department of Defense to boost US rare earth magnet supply, shares soar (Reuters)
06:00AM	MP Materials Announces Transformational Public-Private Partnership with the Department of Defense to Accelerate U.S. Rare Earth Magnet Independence (Business Wire)
Jul-07-25 12:20PM	Jefferies downgrades MP Materials as China eases rare earth restrictions (Investing.com)
Jul-02-25 06:02PM	Why MP Materials Stock Powered Almost 53% Higher in June (Motley Fool)
01:31PM	Palantir, Tesla, And Nvidia Rewarded Patient Investors. Now, An Investor Is Asking, 'What Are You Currently Bullish On For The Long Term?' (Benzinga)
Jun-30-25 01:21PM	Trade Tracker: Jim Lebenthal sells MP Materials (CNBC TV)
Jun-27-25 03:42PM	Why Shares in Rare Earth Company MP Materials Crashed Today (Motley Fool) -8.59%
11:50AM	Top Stock Movers Now: Nike, Boeing, MP Materials, and More (Investopedia)
10:57AM	Not everyone is happy about the U.S.-China breakthrough on rare earths (MarketWatch)
10:49AM	Beijing Lifts Rare-Earth Curbs; MP Materials Dives As S&P 500 Sails (Investor's Business Daily)
10:12AM	MP Materials, USA Rare Earth Stocks Drop on US-China Deal (Investopedia)
09:31AM	Stocks to Watch Friday: Nike, Xiaomi, MP Materials (The Wall Street Journal)
08:08AM	Nike shares rally and other early movers (MarketWatch)
03:27AM	Jim Cramer Says He Has "Always Liked MP" (Insider Monkey)
Jun-26-25 10:04AM	MP Materials, FCX Jump On China Rare-Earth Curbs, Trump Tariff Bets (Investor's Business Daily)
08:34AM	UUUU's Donald Project Approved: Will It Drive Its REE Growth Phase? (Zacks)
Jun-25-25 03:52PM	MP Materials, Saudi Arabia's Maaden Partner to Develop Integrated Rare Earth Supply Chain (Insider Monkey)
Jun-24-25 08:56PM	Lightning Round: Jabil is a terrific stock, says Jim Cramer (CNBC TV)
Jun-22-25 02:59PM	MP Materials (MP) Rallies 23.5% W/W on Rosy Prospects (Insider Monkey)
Jun-20-25 03:18PM	Why Shares in Rare Earth Company MP Materials Surged Again This Week (Motley Fool)
11:15AM	Trump Pledge of Quick China Magnet Flows Has Yet to Materialize (Bloomberg)
Jun-17-25 05:28PM	Rare earth deal with China is 'long-term' industrial crisis, says MP Materials CEO (CNBC TV)
02:02PM	MP Materials (MP) Rallies 13.4% on Rare Earths Deal (Insider Monkey)
Jun-16-25 04:05PM	MP Materials to Participate in Upcoming Conferences (Business Wire) +13.42%
02:57PM	U.S.-China Rare Earths Deal May Omit Lockheed Martin's F-35; MP Materials Surges (Investor's Business Daily)
Jun-13-25 09:55AM	Buy This Stock, Says Analyst. The U.S. Needs Rare-Earth Magnets, (Barrons.com)
08:00AM	This Rare Earth Stock Is Soaring as US, China Negotiate. Why It's the Best Way to Play the Trade. (Barrons.com)
Jun-12-25 04:41PM	China grants rare earth export permits after US trade talks, offers relief but uncertainty persists (Associated Press Finance) +13.88%
03:52PM	The Rare Earth Trap: How China Could Cripple America's Tech and Defense in One Move (GuruFocus.com)
03:51PM	Trump Mulls Using Defense Powers to Fund Rare-Earth Projects (Bloomberg)
Jun-11-25 10:54AM	Why MP Materials Stock Plummeted Today (Motley Fool) -5.84%
Jun-10-25 09:18AM	Rare-Earth Miner MP Materials Stock Rallies Amid US-China Trade Talks (Investopedia)
05:40AM	Apple stock struggles to make headway as traders shrug off developers conference (MarketWatch)
Jun-09-25 04:19PM	Why MP Materials Took Off Today (Motley Fool) +7.74%
03:26PM	Stocks to Watch Monday: Qualcomm, Warner Bros., MP Materials (The Wall Street Journal)
Jun-06-25 04:26PM	Critical Minerals Will Remain a Problem in U.S.-China Talks. These Industries Are at Risk. (Barrons.com)
10:06AM	Why Shares of MP Materials Are Soaring This Week (Motley Fool)
Jun-05-25 11:29AM	Trump, Xi Set Next Talks As China Applies Rare-Earths Leverage; MP Materials Surges (Investor's Business Daily) +5.49%
06:04AM	Rare Earth Stocks: Analysts Say Its Time to Jump In (TipRanks)
Jun-04-25 11:50PM	Why MP Materials Corp. (MP) Skyrocketed Today (Insider Monkey) +11.73%
Jun-03-25 02:59AM	Why MP Materials Corp. (MP) Crashed On Monday (Insider Monkey) +7.32%
Jun-02-25 08:27PM	Chinas Rare Earths Grip Gives Xi Leverage in US Trade Duel (Bloomberg) -5.92%
07:17AM	U.S.-China Trade Talks On The Ropes As Tech War Heats Up; S&P 500 Futures Fall (Investor's Business Daily)
May-28-25 04:27AM	Why MP Materials Corp. (MP) Went Down On Tuesday (Insider Monkey)
May-27-25 11:20AM	MP Vs IDR: Which Rare Earth Stock Deserves a Spot in Your Portfolio? (Zacks)
May-22-25 04:37PM	Was Jim Cramer Right About MP Materials Corp. (MP)? (Insider Monkey)
May-20-25 11:40AM	MP Materials & Maaden Ink Deal to Develop Rare Earths Supply Chain (Zacks)
May-15-25 10:16AM	Maaden, MP Materials partner to develop Saudi rare earth supply chain (Mining Technology)
May-14-25 09:25AM	MP Materials, Maaden to jointly develop rare earths supply chain in Saudi (Reuters)
08:18AM	Maaden and MP Materials Collaborate to Establish Full Value Chain for Rare Earth Magnetics (Business Wire)
May-13-25 10:51AM	MP Slides 10% Following Q1 Earnings Miss: How to Play the Stock? (Zacks)
May-09-25 06:11PM	Why MP Materials Stock Plummeted by 8% on Friday (Motley Fool) -7.97%
May-08-25 06:20PM	MP Materials Corp. (MP) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
05:17PM	MP Materials swings to quarterly loss on rising production costs (Reuters)
04:05PM	MP Materials Reports First Quarter 2025 Results (Business Wire)
May-07-25 07:55PM	McEwen (MUX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
01:18PM	MP Materials Q1 2025 Earnings Preview (Seeking Alpha)

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoops Elliot Dean	General Counsel and Secretary	Jul 01 '25	Sale	31.94	6,338	202,464	6,337	Jul 03 09:27 PM
Hoops Elliot Dean	Officer	Jul 01 '25	Proposed Sale	31.90	6,338	202,209		Jul 01 04:36 PM
Hoops Elliot Dean	General Counsel and Secretary	Jun 26 '25	Sale	36.37	5,523	200,872	69,749	Jun 27 09:30 PM
Hoops Elliot Dean	Officer	Jun 26 '25	Proposed Sale	36.33	5,523	200,651		Jun 26 04:17 PM
Hoops Elliot Dean	General Counsel and Secretary	Jun 13 '25	Sale	29.96	5,538	165,918	12,675	Jun 13 09:25 PM
Hoops Elliot Dean	General Counsel and Secretary	Jun 12 '25	Sale	29.95	800	23,960	18,213	Jun 13 09:25 PM
Hoops Elliot Dean	Officer	Jun 13 '25	Proposed Sale	29.96	6,338	189,900		Jun 13 04:30 PM
Litinsky James H.	Chairman and CEO	Apr 14 '25	Sale	27.08	199,180	5,393,794	13,643,076	Apr 16 09:11 PM
Litinsky James H.	Chairman and CEO	Mar 25 '25	Sale	27.03	396,293	10,711,800	13,860,775	Mar 27 09:40 PM
Litinsky James H.	Chairman and CEO	Mar 26 '25	Sale	27.00	18,519	500,013	13,842,256	Mar 27 09:40 PM
Litinsky James H.	Chairman and CEO	Mar 20 '25	Sale	27.04	95,621	2,585,592	14,257,068	Mar 21 09:15 PM
Litinsky James H.	Chairman and CEO	Mar 18 '25	Sale	26.71	639,294	17,075,543	14,513,864	Mar 19 09:18 PM
Litinsky James H.	Chairman and CEO	Mar 17 '25	Sale	26.77	489,918	13,115,105	15,153,158	Mar 19 09:18 PM
Litinsky James H.	Chairman and CEO	Mar 19 '25	Sale	26.94	161,175	4,342,054	14,352,689	Mar 19 09:18 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Mar 19 '25	Proposed Sale	26.83	788,356	21,151,591		Mar 19 05:04 PM
Corbett Ryan	Chief Financial Officer	Mar 14 '25	Sale	25.51	60,000	1,530,391	230,100	Mar 18 06:45 PM
Corbett Ryan	Chief Financial Officer	Mar 17 '25	Sale	27.00	15,000	405,000	214,812	Mar 18 06:45 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Mar 18 '25	Proposed Sale	26.69	721,726	19,262,867		Mar 18 05:06 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Mar 17 '25	Proposed Sale	26.83	489,918	13,144,500		Mar 17 05:05 PM
Corbett Ryan	Officer	Mar 17 '25	Proposed Sale	27.00	15,000	405,000		Mar 17 04:03 PM
Corbett Ryan	Officer	Mar 14 '25	Proposed Sale	25.00	60,000	1,500,000		Mar 14 04:09 PM
Litinsky James H.	Chairman and CEO	Feb 04 '25	Sale	24.01	386,223	9,273,214	15,643,076	Feb 06 09:13 PM
Litinsky James H.	Chairman and CEO	Dec 03 '24	Sale	23.39	1,579,110	36,934,246	16,029,299	Dec 04 07:37 PM
Litinsky James H.	Chairman and CEO	Dec 02 '24	Sale	20.68	234,667	4,852,914	17,608,409	Dec 04 07:37 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Dec 03 '24	Proposed Sale	20.81	1,200,000	24,972,000		Dec 03 05:01 PM
Litinsky James H.	Chairman and CEO	Nov 26 '24	Sale	20.22	300,000	6,066,000	18,043,076	Nov 29 07:11 PM
Litinsky James H.	Chairman and CEO	Nov 27 '24	Sale	20.90	200,000	4,180,000	17,843,076	Nov 29 07:11 PM
Corbett Ryan	Chief Financial Officer	Nov 29 '24	Sale	21.50	35,000	752,500	260,021	Nov 29 07:00 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Nov 29 '24	Proposed Sale	20.84	1,000,000	20,840,000		Nov 29 01:54 PM
Corbett Ryan	Officer	Nov 29 '24	Proposed Sale	21.50	35,000	752,500		Nov 29 01:12 PM
JAMES HENRY LITINSKY REVOCABLE	Officer	Nov 27 '24	Proposed Sale	20.90	200,000	4,180,420		Nov 27 04:22 PM
JAMES HENRY LITINSKY REVOCABLE	Officer	Nov 26 '24	Proposed Sale	20.22	300,000	6,064,680		Nov 26 04:41 PM
Litinsky James H.	Chairman and CEO	Nov 18 '24	Sale	18.45	300,000	5,535,000	18,221,776	Nov 18 09:35 PM
Corbett Ryan	Chief Financial Officer	Nov 18 '24	Sale	18.30	15,195	278,068	295,021	Nov 18 09:28 PM
Hoops Elliot Dean	General Counsel and Secretary	Nov 15 '24	Sale	18.03	30,000	540,900	8,114	Nov 18 09:23 PM
JAMES HENRY LITINSKY REVOCABLE	Officer	Nov 18 '24	Proposed Sale	18.45	300,000	5,534,760		Nov 18 04:19 PM
Ryan S Corbett	Officer	Nov 18 '24	Proposed Sale	18.29	15,195	277,923		Nov 18 02:13 PM
HOOPS FAMILY TRUST	Officer	Nov 15 '24	Proposed Sale	18.03	30,000	540,921		Nov 15 04:56 PM
Rosenthal Michael Stuart	Chief Operating Officer	Aug 06 '24	Buy	10.84	30,000	325,200	1,402,975	Aug 08 04:23 PM

ROIV

Roivant Sciences Ltd

MP

MP Materials Corporation

Upgrade your FINVIZ experience